Healthcare associated infections of Methicillin-resistant Staphylococcus aureus: A case-control-control study

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Yao, Zhenjiang ^a   Peng, Yang ^a   Chen, Xiaofeng ^b   Bi, Jiaqi ^c   Li, Ying ^a   Ye, Xiaohua ^a   Shi, Jing ^d  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b Division of Infectious Diseases   (China)

^c Department of Environmental and School Health   (China)

^d HEBEI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFAZOLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; OXACILLIN; PENICILLIN DERIVATIVE; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENDOTRACHEAL INTUBATION; HEALTHCARE ASSOCIATED INFECTION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; RISK FACTOR; VENTILATOR; CHINA; CLASSIFICATION; COMPARATIVE STUDY; CROSS INFECTION; DISK DIFFUSION; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TERTIARY CARE CENTER;

ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CHINA; CROSS INFECTION; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TERTIARY CARE CENTERS;

EID: 84948956202     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140604     Document Type: Article

References (27)

1. ERIKSEN KR. "Celbenin"-resistant staphylococci. Ugeskr Laeger. 1961; 123: 384-386. PMID: 13697147
2. Rasmussen G, Monecke S, Brus O, Ehricht R, Soderquist B. Long term epidemiology of methicillinresistant Staplylococcus aureus bacteria isolates in Sweden. PLoS One. 2014; 9: e114276.
3. Ghirardi B, Pietrasanta C, Ciuffini F, Manca MF, Uccella S, Lavizzari A, et al. Management of outbreaks of nosocomial pathogens in neonatal intensive care unit. Pediatr Med Chir. 2013; 35: 263-268. PMID: 24620553
4. Xiao M, Wang H, Zhao Y, Mao LL, Brown M, Yu YS, et al. National surveillance of methicillin-resistant Staphylococcus aureus in China highlights a still-evolving epidemiology with 15 novel emerging multilocus sequence types. J Clin Microbiol. 2013; 51: 3638-3644. doi: 10.1128/JCM.01375-13 PMID: 23985906
5. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006; 42: S82-S89. PMID: 16355321
6. Park DA, Lee SM, Peck KR, Joo EJ, Oh EG. Impact of Methicillin-Resistance on Mortality in Children and Neonates with Staphylococcus aureus Bacteremia: A Meta-analysis. Infect Chemother. 2013; 45: 202-210. doi: 10.3947/ic.2013.45.2.202 PMID: 24265968
7. Lodise TP, McKinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis. 2005; 52: 113-122. PMID: 15964499
8. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005; 26: 166-174. PMID: 15756888
9. Zhao C, Sun H, Wang H, Liu Y, Hu B, Yu Y, et al. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010). Diagn Microbiol Infect Dis. 2012; 73: 174-181. doi: 10.1016/j.diagmicrobio.2012.03.003 PMID: 22521693
10. Xiao YH, Giske CG, Wei ZQ, Shen P, Heddini A, Li LJ. Epidemiology and characteristics of antimicrobial resistance in China. Drug Resist Updat. 2011; 14: 236-250. doi: 10.1016/j.drup.2011.07.001 PMID: 21807550
11. Li T, Song Y, Zhu Y, Du X, Li M. Current status of Staphylococcus aureus infection in a central teaching hospital in Shanghai, China. BMC Microbiol. 2013; 13: 153. doi: 10.1186/1471-2180-13-153 PMID: 23834674
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute; 2013.
13. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48: 1-12. doi: 10.1086/595011 PMID: 19035777
14. Jones RN, Castanheira M, Hu B, Ni Y, Lin SS, Mendes RE, et al. Update of contemporary antimicrobial resistance rates across China: reference testing results for 12 medical centers (2011). Diagn Microbiol Infect Dis. 2013; 77: 258-266. doi: 10.1016/j.diagmicrobio.2013.07.003 PMID: 24055218
15. Sun DD, Ma XX, Hu J, Tian Y, Pang L, Shang H, et al. Epidemiological and molecular characterization of community and hospital acquired Staphylococcus aureus strains prevailing in Shenyang, Northeastern China. Braz J Infect Dis. 2013; 17: 682-690. doi: 10.1016/j.bjid.2013.02.007 PMID: 23916451
16. Rongpharpi SR, Hazarika NK, Kalita H. The prevalence of nasal carriage of Staphylococcus aureus among healthcare workers at a tertiary care hospital in assam with special reference to MRSA. J Clin Diagn Res. 2013; 7: 257-260. doi: 10.7860/JCDR/2013/4320.2741 PMID: 23543837
17. Kahsay A, Mihret A, Abebe T, Andualem T. Isolation and antimicrobial susceptibility pattern of Staphylococcus aureus in patients with surgical site infection at Debre Markos Referral Hospital, Amhara Region, Ethiopia. Arch Public Health. 2014; 72:16. doi: 10.1186/2049-3258-72-16 PMID: 24949197
18. Fuda C, Suvorov M, Vakulenko SB, Mobashery S. The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus. J Biol Chem. 2004; 279: 40802-40806. PMID: 15226303
19. van Hal SJ, Steen JA, Espedido BA, Grimmond SM, Cooper MA, Holden MT, et al. In vivo evoluation of antimicrobial resistance in a series of Staphylococcus aureus patients isolates: the entire picture or a cautionary tale? J Antimicrob Chemother. 2014; 69: 363-367. doi: 10.1093/jac/dkt354 PMID: 24047554
20. Fascia DT, Singanayagam A, Keating JF. Methicillin-resistant Staphylococcus aureus in orthopaedic trauma: identification of risk factors as a strategy for control of infection. J Bone Joint Surg Br. 2009; 91: 249-252. doi: 10.1302/0301-620X.91B2.21339 PMID: 19190063
21. March A, Aschbacher R, Dhanji H, Livermore DM, Bottcher A, Sleghel F, et al. Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin Microbiol Infect. 2010; 16: 934-944. doi: 10.1111/j.1469-0691.2009.03024.x PMID: 19686277
22. Chen CC, Pass SE. Risk factors for and impact of methicillin-resistant Staphylococcus aureus nasal colonization in patients in a medical intensive care unit. Am J Infect Control. 2013; 41:1100-1101. doi: 10.1016/j.ajic.2013.01.035 PMID: 23663856
23. Abe Y, Shigemura K, Yoshida H, Fujisawa M, Arakawa S. Risk factors for anti-MRSA drug resistance. Int J Antimicrob Agents. 2012; 40: 423-426. doi: 10.1016/j.ijantimicag.2012.07.005 PMID: 22999766
24. Porto JP, Santos RO, Gontijo FP, Ribas RM. Active surveillance to determine the impact of methicillin resistance on mortality in patients with bacteremia and influences of the use of antibiotics on the development of MRSA infection. Rev Soc Bras Med Trop. 2013; 46: 713-718. doi: 10.1590/0037-8682-0199-2013 PMID: 24474012
25. Harinstein L, Schafer J, D'Amico F. Risk factors associated with the conversion of methicillin-resistant Staphylococcus aureus colonization to healthcare-associated infection. J Hosp Infect. 2011; 79: 194-197. doi: 10.1016/j.jhin.2011.03.017 PMID: 21640432
26. Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust. 2001; 175: 264-267. PMID: 11587259
27. Kaasch AJ, Barlow G, Edgeworth JD, Fowler VG, Hellmich M, Hopkins S, et al. Staphylococcus aureus bloodstream infection: a pooled analysis of five perspective, observational studies. J Infect. 2014; 68: 242-251. doi: 10.1016/j.jinf.2013.10.015 PMID: 24247070